These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 12107547

  • 1. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I, Sugiyama H, Kanazawa S, Hemmi H.
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB.
    Cancer Res; 1994 Nov 01; 54(21):5607-13. PubMed ID: 7923205
    [Abstract] [Full Text] [Related]

  • 3. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
    Kotchetkov R, Driever PH, Cinatl J, Michaelis M, Karaskova J, Blaheta R, Squire JA, Von Deimling A, Moog J, Cinatl J.
    Int J Oncol; 2005 Oct 01; 27(4):1029-37. PubMed ID: 16142320
    [Abstract] [Full Text] [Related]

  • 4. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
    Keshelava N, Seeger RC, Groshen S, Reynolds CP.
    Cancer Res; 1998 Dec 01; 58(23):5396-405. PubMed ID: 9850071
    [Abstract] [Full Text] [Related]

  • 5. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA, Michaelis M, Natsheh I, Hasenberg C, Weich E, Relja B, Jonas D, Doerr HW, Cinatl J.
    Br J Cancer; 2007 Jun 04; 96(11):1699-706. PubMed ID: 17505515
    [Abstract] [Full Text] [Related]

  • 6. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 04; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 7. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
    Flahaut M, Mühlethaler-Mottet A, Martinet D, Fattet S, Bourloud KB, Auderset K, Meier R, Schmutz NB, Delattre O, Joseph JM, Gross N.
    Genes Chromosomes Cancer; 2006 May 04; 45(5):495-508. PubMed ID: 16450357
    [Abstract] [Full Text] [Related]

  • 8. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I, Brisson C, Fabre M, Bergerat JP, Rebel G.
    Anticancer Res; 2008 May 04; 28(1A):55-68. PubMed ID: 18383825
    [Abstract] [Full Text] [Related]

  • 9. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F, Jongsma AP, Broxterman HJ, Arceci RJ, Housman D, Scheffer GL, Riethorst A, van Groenigen M, Nieuwint AW, Joenje H.
    Cancer Res; 1990 Sep 01; 50(17):5392-8. PubMed ID: 1974823
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP.
    J Natl Cancer Inst; 2007 Jul 18; 99(14):1107-19. PubMed ID: 17623797
    [Abstract] [Full Text] [Related]

  • 11. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
    Guo H, Lu G, Xiong X, Dong J, Liu S.
    Chin Med J (Engl); 1997 Mar 18; 110(3):167-72. PubMed ID: 9594332
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY, Mirkin BL, Dwivedi RS.
    Cancer Detect Prev; 2005 Mar 18; 29(5):456-63. PubMed ID: 16185816
    [Abstract] [Full Text] [Related]

  • 13. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y, Takano H, Nagao S, Fojo T.
    Jpn J Cancer Res; 2001 Sep 18; 92(9):968-74. PubMed ID: 11572765
    [Abstract] [Full Text] [Related]

  • 14. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JR, Pierre KM, Turpie BW, Hamilton JW.
    Clin Cancer Res; 1997 Aug 18; 3(8):1339-46. PubMed ID: 9815817
    [Abstract] [Full Text] [Related]

  • 15. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 18; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 16. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR, van der Bliek AM, Schuurhuis GJ, van der Velde-Koerts T, Smit JJ, Borst P.
    Cancer Res; 1990 Mar 15; 50(6):1779-85. PubMed ID: 1968359
    [Abstract] [Full Text] [Related]

  • 17. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E.
    Cancer Res; 1986 Sep 15; 46(9):4379-83. PubMed ID: 3731096
    [Abstract] [Full Text] [Related]

  • 18. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX, Luo Y, Qiu HM, Tang WX.
    Saudi Med J; 2009 Jan 15; 30(1):35-40. PubMed ID: 19139770
    [Abstract] [Full Text] [Related]

  • 19. Development of multidrug resistance in a canine lymphoma cell line.
    Uozurmi K, Nakaichi M, Yamamoto Y, Une S, Taura Y.
    Res Vet Sci; 2005 Jun 15; 78(3):217-24. PubMed ID: 15766940
    [Abstract] [Full Text] [Related]

  • 20. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin.
    Yang X, Pagé M.
    Oncol Res; 1995 Jun 15; 7(12):619-24. PubMed ID: 8704279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.